146 related articles for article (PubMed ID: 33596246)
1. Downregulation of PAICS due to loss of chromosome 4q is associated with poor survival in stage III colorectal cancer.
Kobayashi Y; Kumamoto K; Okayama H; Matsumoto T; Nakano H; Saito K; Matsumoto Y; Endo E; Kanke Y; Watanabe Y; Onozawa H; Fujita S; Sakamoto W; Saito M; Momma T; Takenoshita S; Kono K
PLoS One; 2021; 16(2):e0247169. PubMed ID: 33596246
[TBL] [Abstract][Full Text] [Related]
2. Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer.
Chakravarthi BV; Goswami MT; Pathi SS; Dodson M; Chandrashekar DS; Agarwal S; Nepal S; Hodigere Balasubramanya SA; Siddiqui J; Lonigro RJ; Chinnaiyan AM; Kunju LP; Palanisamy N; Varambally S
Prostate; 2017 Jan; 77(1):10-21. PubMed ID: 27550065
[TBL] [Abstract][Full Text] [Related]
3. Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.
Goswami MT; Chen G; Chakravarthi BV; Pathi SS; Anand SK; Carskadon SL; Giordano TJ; Chinnaiyan AM; Thomas DG; Palanisamy N; Beer DG; Varambally S
Oncotarget; 2015 Sep; 6(27):23445-61. PubMed ID: 26140362
[TBL] [Abstract][Full Text] [Related]
4. PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer.
Agarwal S; Chakravarthi BVSK; Behring M; Kim HG; Chandrashekar DS; Gupta N; Bajpai P; Elkholy A; Balasubramanya SAH; Hardy C; Diffalha SA; Varambally S; Manne U
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32218208
[TBL] [Abstract][Full Text] [Related]
5. PAICS contributes to gastric carcinogenesis and participates in DNA damage response by interacting with histone deacetylase 1/2.
Huang N; Xu C; Deng L; Li X; Bian Z; Zhang Y; Long S; Chen Y; Zhen N; Li G; Sun F
Cell Death Dis; 2020 Jul; 11(7):507. PubMed ID: 32632107
[TBL] [Abstract][Full Text] [Related]
6. A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.
Chakravarthi BVSK; Rodriguez Pena MDC; Agarwal S; Chandrashekar DS; Hodigere Balasubramanya SA; Jabboure FJ; Matoso A; Bivalacqua TJ; Rezaei K; Chaux A; Grizzle WE; Sonpavde G; Gordetsky J; Netto GJ; Varambally S
Neoplasia; 2018 Sep; 20(9):894-904. PubMed ID: 30121007
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines.
Meng M; Chen Y; Jia J; Li L; Yang S
Biol Res; 2018 Aug; 51(1):24. PubMed ID: 30097015
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target.
Škerlová J; Unterlass J; Göttmann M; Marttila P; Homan E; Helleday T; Jemth AS; Stenmark P
J Biol Chem; 2020 Aug; 295(33):11656-11668. PubMed ID: 32571877
[TBL] [Abstract][Full Text] [Related]
9. Zebrafish mutations in gart and paics identify crucial roles for de novo purine synthesis in vertebrate pigmentation and ocular development.
Ng A; Uribe RA; Yieh L; Nuckels R; Gross JM
Development; 2009 Aug; 136(15):2601-11. PubMed ID: 19570845
[TBL] [Abstract][Full Text] [Related]
10. PAICS deficiency, a new defect of de novo purine synthesis resulting in multiple congenital anomalies and fatal outcome.
Pelet A; Skopova V; Steuerwald U; Baresova V; Zarhrate M; Plaza JM; Hnizda A; Krijt M; Souckova O; Wibrand F; Andorsdóttir G; Joensen F; Sedlak D; Bleyer AJ; Kmoch S; Lyonnet S; Zikanova M
Hum Mol Genet; 2019 Nov; 28(22):3805-3814. PubMed ID: 31600779
[TBL] [Abstract][Full Text] [Related]
11. NDST4 is a novel candidate tumor suppressor gene at chromosome 4q26 and its genetic loss predicts adverse prognosis in colorectal cancer.
Tzeng ST; Tsai MH; Chen CL; Lee JX; Jao TM; Yu SL; Yen SJ; Yang YC
PLoS One; 2013; 8(6):e67040. PubMed ID: 23825612
[TBL] [Abstract][Full Text] [Related]
12. Genetic and metabolomic analysis of AdeD and AdeI mutants of de novo purine biosynthesis: cellular models of de novo purine biosynthesis deficiency disorders.
Duval N; Luhrs K; Wilkinson TG; Baresova V; Skopova V; Kmoch S; Vacano GN; Zikanova M; Patterson D
Mol Genet Metab; 2013 Mar; 108(3):178-189. PubMed ID: 23394948
[TBL] [Abstract][Full Text] [Related]
13. KRT17 as a prognostic biomarker for stage II colorectal cancer.
Ujiie D; Okayama H; Saito K; Ashizawa M; Thar Min AK; Endo E; Kase K; Yamada L; Kikuchi T; Hanayama H; Fujita S; Sakamoto W; Endo H; Saito M; Mimura K; Saze Z; Momma T; Ohki S; Kono K
Carcinogenesis; 2020 Jul; 41(5):591-599. PubMed ID: 31754689
[TBL] [Abstract][Full Text] [Related]
14. Roles of highly expressed PAICS in lung adenocarcinoma.
Zhou S; Yan Y; Chen X; Wang X; Zeng S; Qian L; Wei J; Yang X; Zhou Y; Gong Z; Xu Z
Gene; 2019 Apr; 692():1-8. PubMed ID: 30641222
[TBL] [Abstract][Full Text] [Related]
15. PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression.
Agarwal S; Chakravarthi BVSK; Kim HG; Gupta N; Hale K; Balasubramanya SAH; Oliver PG; Thomas DG; Eltoum IA; Buchsbaum DJ; Manne U; Varambally S
Transl Oncol; 2020 Jul; 13(7):100776. PubMed ID: 32422575
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.
Li C; Cai S; Wang X; Jiang Z
PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
18. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
19. Multienzyme interactions of the de novo purine biosynthetic protein PAICS facilitate purinosome formation and metabolic channeling.
He J; Zou LN; Pareek V; Benkovic SJ
J Biol Chem; 2022 May; 298(5):101853. PubMed ID: 35331738
[TBL] [Abstract][Full Text] [Related]
20. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
